Menu
At Inoviem, we pride ourselves on offering comprehensive and meticulously managed human biological samples provision services to support cutting-edge research and development initiatives. Our capabilities extend beyond simple sample collection— we design and implement prospective tissue collection programs that cater to a wide range of clinical indications. Whether your research is focused on oncology, respiratory, dermatology, autoimmune, inflammatory conditions, or other disease areas, Inoviem is equipped to deliver high-quality biological materials that meet the highest standards of integrity and compliance.
We collaborate with clinical partners and healthcare institutions to establish prospective tissue collection protocols customized to your study’s requirements. Our services include collecting matched biopsies and various specimen types – such as peripheral blood mononuclear cells (PBMCs), plasma, sera, urine, whole blood, sputum, and more – to ensure you have access to the critical materials needed for exploring disease mechanisms, identifying biomarkers, and evaluating therapeutic responses.
Inoviem has formed a partnership with the Kyrgyz State Medical Academy (KSMA) in Bishkek, Kyrgyzstan’s capital, where we have established dedicated laboratories for patient characterization and sample preparation. Patients in this region are generally naive to modern treatments and personalized medicine approaches, such as monoclonal antibody-based therapies (e.g., anti-PD1). Additionally, the local population is highly diverse, including individuals from China, Russia, Turkey, India, as well as native Kyrgyz citizens.
Inoviem has direct access to the following disease areas:
Depending on the indication, Inoviem can collect:
Inoviem supports a variety of sample types and preservation methods:
Specializing in human-derived pathological tissues, our technologies integrate clinical realities into research programs. We develop and execute custom assays to test drugs directly on diseased tissue, with routine efficacy and safety evaluations for ex-vivo translational pharmacology. This approach bridges the gap between preclinical insights and clinical development.
Our state-of-the-art biobank is central to our service, operating under stringent guidelines and industry best practices. Every sample is collected, processed, and stored under optimal conditions to preserve its integrity and biological relevance. Rigorous quality control measures and comprehensive tracking systems ensure reliable, reproducible data for your research.
Inoviem not only excels in single-point sample collection but also in designing and executing longitudinal and follow-up studies. Recognizing that dynamic biomarker changes are crucial for understanding disease progression and treatment efficacy, we enable continuous sample collection and monitoring over extended periods in clinical settings.
From designing collection protocols to final sample storage and distribution, our holistic approach supports your research from start to finish. Our experienced team is dedicated to excellence and innovation in human tissue collection and biobanking, ensuring your research is backed by robust, high-quality biological data.
Learn how Inoviem’s Human Biological Samples Provision can enhance your research capabilities, empower clinical studies, and drive breakthroughs in disease understanding and treatment development.
